A Look at Novartis' Cosentyx in treating Hidradenitis Suppurativa and how it can compete with Humira

Scheduled for:Aug 7, 2022 8:00 PM EDT

Call Duration:30 minutes

Desired Expert

Dermatologist with extensive knowledge of hidradenitis suppurativa treatment methods.

Interview Goal

Discussing the the standard of care and the competitive landscape between ABBV Humira and NVS Cosentyx, as well as the clinical studies of treatments such as ANAB imsidolimab.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.